Planned phase II trial of 72-h oxymorphone transdermal patch

Trial Profile

Planned phase II trial of 72-h oxymorphone transdermal patch

Planning
Phase of Trial: Phase II

Latest Information Update: 14 May 2015

At a glance

  • Drugs Oxymorphone (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 May 2015 Planned initiation date changed from 1 Jun 2015 to 1 Sep 2016, according to a Phosphagenics media release.
    • 11 Aug 2014 Planned initiation date changed from 1 Jun 2014 to 1 Jun 2015 according to a Phosphagenics media release.
    • 26 Jul 2013 Planned initiation date changed from 1 Jun 2013 to 1 Jun 2014, based on information in a Phosphagenics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top